Psoriasis patients and disease risk

Patients with psoriasis are more likely to have a wide range of other conditions, from metabolic disorders to peptic ulcers, a study has shown

Researchers led by Dr Heng-Ching Lin from Taipei Medical University Hospital in Taiwan compared the prevalence of comorbidities among 1,685 local adult patients with psoriasis with that among 5,055 control patients.

They found that patients with psoriasis had a 63% greater risk of developing congestive heart failure, a 51% greater risk of heart disease and a 45% greater risk of renal failure. Patients with psoriasis also had a greater than 20% raised risk of developing uncomplicated diabetes, hyperlipidaemia, hypertension and peptic ulcer.

The researchers said doctors should be aware of the risks of comorbidities, assess patients and, when appropriate, provide suitable care to reduce 'the unnecessary development of associated morbidity and mortality'.
Yang YW, Keller JJ, Lin HC. Br J Dermatol 2011; 165: 1037-43

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Psychological side-effects of skin disease

Clinicians should consider the pyschological effects...

Keratinocyte apoptosis in clearance of psoriasis

UK researchers have shown that keratinocyte apoptosis...

Biologics for chronic plaque psoriasis

Researchers have investigated biologics for chronic...

1.5 CPD credits: Management of chronic plaque psoriasis

Therapeutics have improved, especially with new biological...

Management of scalp psoriasis in primary care

Management of scalp psoriasis in primary care

Patients will be better motivated to persist with treatment...

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more